Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies

Induction of broadly neutralizing antibodies (bnAbs) is a goal of HIV-1 vaccine development. bnAbs occur in some HIV-1–infected individuals and frequently have characteristics of autoantibodies. We have studied cohorts of HIV-1–infected individuals who made bnAbs and compared them with those who did...

全面介紹

書目詳細資料
Main Authors: Moody, M, Pedroza-Pacheco, I, Vandergrift, N, Chui, C, Lloyd, K, Parks, R, Ogbe, A, Cohen, M, Liao, H, Gao, F, McMichael, A, Montefiori, D, Verkoczy, L, Kelsoe, G, Huang, J, Shea, P, Connors, M, Borrow, P, Haynes, B
格式: Journal article
出版: American Association for the Advancement of Science 2016
實物特徵
總結:Induction of broadly neutralizing antibodies (bnAbs) is a goal of HIV-1 vaccine development. bnAbs occur in some HIV-1–infected individuals and frequently have characteristics of autoantibodies. We have studied cohorts of HIV-1–infected individuals who made bnAbs and compared them with those who did not do so, and determined immune traits associated with the ability to produce bnAbs. HIV-1–infected individuals with bnAbs had a higher frequency of blood autoantibodies, a lower frequency of regulatory CD4+ T cells, a higher frequency of circulating memory T follicular helper CD4+ cells, and a higher T regulatory cell level of programmed cell death–1 expression compared with HIV-1–infected individuals without bnAbs. Thus, induction of HIV-1 bnAbs may require vaccination regimens that transiently mimic immunologic perturbations in HIV-1–infected individuals.